The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Haumann Brett K since 2016.
The trader's CIK number is 1607733.
At the time of the last reporting, Haumann Brett K was the Chief Medical Officer of Theravance Biopharma, Inc.. (stock ticker symbol TBPH).
Also see all insider trading activities at Theravance Biopharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | TBPH | 0 | $0 | 25,000 | $457,250 | 0 | $0 |
| 2017 | TBPH | 0 | $0 | 14,000 | $440,974 | 0 | $0 |
| 2016 | TBPH | 0 | $0 | 14,000 | $391,669 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-08-21 | TBPH | Sale | 25,000 | 18.29 | 457,250 |
| 2017-03-07 | TBPH | Sale | 424 | 30.80 | 13,059 |
| 2017-03-06 | TBPH | Sale | 13,576 | 31.52 | 427,915 |
| 2016-08-25 | TBPH | Sale | 4,491 | 27.99 | 125,703 |
| 2016-08-19 | TBPH | Sale | 9,509 | 27.97 | 265,966 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Haumann Brett K (Chief Medical Officer of Theravance Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.